Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
24432 ARTÍCULOS , VIENDO DEL 20896 AL 20910
The protective role of exercise against age-related neurodegeneration
Sujkowski A, Hong L, Wessells RJ, Todi SV.
Ageing Res Rev. 2022 Feb;74:101543. doi: 10.1016/j.arr.2021.101543. Epub 2021 Dec 17.
CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
Bhardwaj S, Kesari KK, Rachamalla M, Mani S, Ashraf GM, Jha SK, Kumar P, Ambasta RK, Dureja H, Devkota HP, Gupta G, Chellappan DK, Singh SK, Dua K, Ruokolainen J, Kamal MA, Ojha S, Jha NK.
J Adv Res. 2022 Sep;40:207-221. doi: 10.1016/j.jare.2021.07.001. Epub 2021 Jul 6.
Insight γ-Secretase: Structure, Function, and Role in Alzheimer's Disease
Mal S, Malik U, Pal D, Mishra A.
Curr Drug Targets. 2021;22(12):1376-1403. doi: 10.2174/1389450121999201230203709.
[Causes and Consequences of Genome Instability in Psychiatric and Neurodegenerative Diseases]
Iourov IY, Vorsanova SG, Kurinnaia OS, Zelenova MA, Vasin KS, Yurov YB.
Mol Biol (Mosk). 2021 Jan-Feb;55(1):42-53. doi: 10.31857/S0026898421010158.
DNA Damage-Induced Neurodegeneration in Accelerated Ageing and Alzheimer's Disease
Wang H, Lautrup S, Caponio D, Zhang J, Fang EF.
Int J Mol Sci. 2021 Jun 23;22(13):6748. doi: 10.3390/ijms22136748.
Magham SV, Thaggikuppe Krishnamurthy P, Shaji N, Mani L, Balasubramanian S.
J Neurosci Res. 2021 Nov;99(11):2888-2905. doi: 10.1002/jnr.24933. Epub 2021 Sep 6.
Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease
Lane DJR, Metselaar B, Greenough M, Bush AI, Ayton SJ.
Essays Biochem. 2021 Dec 22;65(7):925-940. doi: 10.1042/EBC20210017.
REM sleep behaviour disorder in patients without synucleinopathy
Keir LHM, Breen DP.
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1239-1240. doi: 10.1136/jnnp-2020-323475. Epub 2020 Aug 13.
Richards K, Morrison J, Wang YY, Rangel A, Loera A, Hanlon A, Lozano A, Kovach C, Gooneratne N, Fry L, Allen R.
Res Gerontol Nurs. 2020 Nov 1;13(6):280-288. doi: 10.3928/19404921-20200918-01. Epub 2020 Sep 24.
Effects of Myricitrin and Relevant Molecular Mechanisms
Zhang X, Zhang K, Wang Y, Ma R.
Curr Stem Cell Res Ther. 2020;15(1):11-17. doi: 10.2174/1574888X14666181126103338.
Fathy YY, Hoogers SE, Berendse HW, van der Werf YD, Visser PJ, de Jong FJ, van de Berg WDJ.
Brain Imaging Behav. 2020 Dec;14(6):2799-2816. doi: 10.1007/s11682-019-00099-3.
Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study
Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT; AETIONOMY study group.
Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.
Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool
Ha ZY, Mathew S, Yeong KY.
Curr Protein Pept Sci. 2020;21(1):99-109. doi: 10.2174/1389203720666191107094949.
Isaev NK, Stelmashook EV, Genrikhs EE.
Rev Neurosci. 2020 Apr 28;31(3):233-243. doi: 10.1515/revneuro-2019-0052.
Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy
Lee JY, Jin HK, Bae JS.
BMB Rep. 2020 Jan;53(1):28-34. doi: 10.5483/BMBRep.2020.53.1.278.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.